Weight loss is the most visible change, with clinical trials demonstrating average reductions that vary by medication: approximately 5-10% with liraglutide (Saxenda), 15-17% with semaglutide 2.4mg (Wegovy) in the STEP trials, and up to 20% with higher doses of tirzepatide in the SURMOUNT programme
Storage and Laboratory Handling Storage: Store at -20C for long-term stability
If tiredness persists or worsens, contact your GP or diabetes specialist nurse for assessment, as fatigue may indicate hypoglycaemia, dehydration, nutritional deficiencies, or other underlying conditions requiring investigation
Shelf life shifts with the specific peptide, the solvent, the storage temperature, and how many times a needle has pierced the stopper
Allergic Reaction Allergic reactions can occur after receiving fat dissolving injections, although they are rare
KPV is especially known for helping regulate inflammation, which can support faster and more efficient recovery